Laura P Hale Selected Research

2- amino- 6- chloro- 9- ((5- dihydroxyboryl)pentyl)purine

3/2008

Treatment of experimental colitis in mice with LMP-420, an inhibitor of TNF transcription.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Laura P Hale Research Topics

Disease

20	Inflammation (Inflammations) 01/2020 - 02/2004
9	Colitis 01/2020 - 07/2005
8	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 12/2010 - 02/2004
8	Neoplasms (Cancer) 12/2010 - 08/2002
8	DiGeorge Syndrome (Syndrome, DiGeorge) 01/2009 - 08/2003
5	Infections 01/2022 - 09/2005
5	Ulcerative Colitis 01/2020 - 07/2005
3	Weight Loss (Weight Reduction) 12/2020 - 08/2005
3	Colonic Neoplasms (Colon Cancer) 01/2012 - 12/2007
3	Helicobacter Infections 08/2010 - 10/2008
3	Alopecia (Baldness) 06/2010 - 08/2003
3	Exanthema (Rash) 10/2004 - 08/2003
3	Lymphadenopathy 10/2004 - 08/2003
2	Human Influenza (Influenza) 12/2020 - 10/2018
2	Cachexia 09/2010 - 08/2002
2	Crohn Disease (Crohn's Disease) 03/2008 - 07/2005
2	Hypothyroidism 05/2007 - 08/2003
2	X-Linked Combined Immunodeficiency Diseases (X Linked Severe Combined Immunodeficiency) 01/2004 - 01/2004
1	Obesity 12/2020
1	Colorectal Neoplasms (Colorectal Cancer) 01/2020
1	Hyper-IgM Immunodeficiency Syndrome (Hyper-IgM Syndrome) 01/2020
1	Rabies (Hydrophobia) 01/2019
1	Tetanus 01/2019
1	Anorexia 01/2016
1	Buruli Ulcer 09/2015
1	Cicatrix (Scar) 09/2015
1	Ischemia 09/2013
1	Pain (Aches) 07/2012
1	Anemia 01/2012
1	Hypersensitivity (Allergy) 01/2012
1	Iron Deficiencies 01/2012
1	Peptic Ulcer (Peptic Ulcers) 01/2011
1	Kaposi Sarcoma (Kaposi's Sarcoma) 05/2009
1	Carcinogenesis 05/2009
1	Thyroid Diseases (Thyroid Disease) 01/2009
1	Coinfection 12/2007
1	Enteritis 05/2007
1	Bacterial Vaginosis 11/2005
1	Dermatitis 08/2005
1	Mucositis 08/2005

Drug/Important Bio-Agent (IBA)

9	Interleukin-10 (Interleukin 10)IBA 01/2020 - 12/2005
8	CytokinesIBA 01/2016 - 12/2007
6	AntigensIBA 01/2019 - 06/2009
6	Bromelains (Bromelain)IBA 12/2010 - 02/2004
5	Piroxicam (Feldene)FDA LinkGeneric 01/2011 - 08/2005
4	IronIBA 01/2016 - 06/2010
4	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 01/2012 - 12/2005
3	Proteins (Proteins, Gene)FDA Link 01/2022 - 08/2002
3	EnzymesIBA 01/2020 - 01/2003
3	VaccinesIBA 09/2015 - 02/2009
3	Immunoglobulin E (IgE)IBA 01/2012 - 08/2003
3	Peptide Hydrolases (Proteases)FDA Link 12/2010 - 08/2005
3	InterleukinsIBA 08/2010 - 12/2005
2	Anti-Bacterial Agents (Antibiotics)IBA 01/2012 - 12/2008
2	Biological ProductsIBA 01/2012 - 08/2002
2	Oxygen (Dioxygen)IBA 01/2012 - 04/2002
2	Pharmaceutical PreparationsIBA 12/2010 - 04/2002
2	Messenger RNA (mRNA)IBA 08/2010 - 08/2002
2	Oligonucleotide ProbesIBA 11/2005 - 07/2005
2	T-Cell Antigen Receptors (T-Cell Receptor)IBA 09/2005 - 04/2004
2	MitogensIBA 10/2004 - 04/2004
1	GTP Phosphohydrolases (GTPases)IBA 01/2022
1	Glucose (Dextrose)FDA LinkGeneric 12/2020
1	Metformin (Glucophage)FDA LinkGeneric 12/2020
1	Cytidine DeaminaseIBA 01/2020
1	Immunoglobulin IsotypesIBA 01/2020
1	Polysaccharides (Glycans)IBA 01/2019
1	Immunoglobulin M (IgM)IBA 01/2019
1	LeptinIBA 01/2016
1	Analgesics (Analgesic Drugs)IBA 07/2012
1	Dietary IronIBA 01/2012
1	AllergensIBA 01/2012
1	Histamine Antagonists (Antihistamines)IBA 01/2011
1	Histamine H1 Receptors (Histamine H1 Receptor)IBA 01/2011
1	Diphenhydramine (Benadryl)FDA LinkGeneric 01/2011
1	Blood Proteins (Serum Proteins)IBA 09/2010
1	CholesterolIBA 09/2010
1	InterferonsIBA 08/2010
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 08/2010
1	Cysteine (L-Cysteine)FDA Link 05/2009
1	Monomeric GTP-Binding ProteinsIBA 05/2009
1	NADPH Oxidases (NAD(P)H oxidase)IBA 05/2009
1	Reactive Oxygen Species (Oxygen Radicals)IBA 05/2009
1	AntioxidantsIBA 05/2009
1	Chemokine ReceptorsIBA 07/2008
1	Anti-Inflammatory Agents (Anti-Inflammatories)IBA 03/2008
1	2- amino- 6- chloro- 9- ((5- dihydroxyboryl)pentyl)purineIBA 03/2008
1	Tumor Necrosis Factor Receptors (Tumor Necrosis Factor Receptor)IBA 03/2008
1	Dextran SulfateIBA 03/2008
1	Type II Tumor Necrosis Factor ReceptorsIBA 03/2008
1	Transforming Growth Factor beta (TGF-beta)IBA 12/2007
1	EndoglinIBA 12/2007
1	Sulindac (Copal)FDA LinkGeneric 12/2005

Therapy/Procedure

7	Therapeutics 01/2012 - 10/2004
7	Transplantation 01/2009 - 01/2003
2	Chemoprevention 12/2008 - 12/2007
2	Aftercare (After-Treatment) 10/2004 - 01/2004
1	Drug Therapy (Chemotherapy) 01/2017
1	Deep Hypothermia Induced Circulatory Arrest 09/2013
1	Oral Administration 03/2008